Status:
UNKNOWN
Molecular Diagnosis and Risk Stratification of Sepsis
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Collaborating Sponsors:
Center for Translational Molecular Medicine
UMC Utrecht
Conditions:
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
Background: Sepsis is a major cause of in-hospital morbidity and mortality. Current tools available to the clinician to initiate therapy of patients with sepsis mainly comprise of symptom classificati...
Eligibility Criteria
Inclusion
- All patients\> 18 years in the Intensive Care Units of the AMC Amsterdam and UMC Utrecht.
Exclusion
- Elective cardiac surgery patients with an uncomplicated stay.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2018
Estimated Enrollment :
7500 Patients enrolled
Trial Details
Trial ID
NCT01905033
Start Date
January 1 2011
End Date
June 1 2018
Last Update
April 29 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Academic Medical Center
Amsterdam, North Holland, Netherlands, 1105 AZ
2
University Medical Center Utrecht
Utrecht, Utrecht, Netherlands, 3584 CX